Gokbayrak, Bengul https://orcid.org/0000-0003-0504-6078
Altintas, Umut Berkay
Lingadahalli, Shreyas
Morova, Tunc
Huang, Chia-Chi Flora https://orcid.org/0000-0002-2150-3139
Ersoy Fazlioglu, Betul
Pak Lok Yu, Ivan
Kalkan, Batuhan M. https://orcid.org/0000-0002-3288-0968
Cejas, Paloma https://orcid.org/0000-0002-2090-7748
Kung, Sonia H. Y. https://orcid.org/0000-0002-9230-8939
Fazli, Ladan
Kawamura, Akane https://orcid.org/0000-0003-1169-5082
Long, Henry W.
Acilan, Ceyda
Onder, Tamer T. https://orcid.org/0000-0002-2372-9158
Bagci-Onder, Tugba https://orcid.org/0000-0003-3646-2613
Lynch, James T. https://orcid.org/0009-0002-8260-5355
Lack, Nathan A. https://orcid.org/0000-0001-7399-5844
Funding for this research was provided by:
TUBITAK
Article History
Received: 28 February 2024
Accepted: 17 December 2024
First Online: 4 February 2025
Competing interests
: James T. Lynch is an AstraZeneca stock holder and a former scientist in AstraZeneca with current employer Amphista Therapeutics (Amphista Therapeutics Ltd, Suite 4 (First Floor), Cori Building, Granta Park, Great Abington, Cambridge, CB21 6GQ).